Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 4,302	$ 21,236
General and administrative	5,234	6,451
Total operating expenses	9,536	27,687
Loss from operations	(9,536)	(27,687)
Other income, net	393	1,350
Net loss	(9,143)	(26,337)
Unrealized (loss) gain on available-for-sale securities	(5)	212
Comprehensive loss attributable to common stockholders	$ (9,148)	$ (26,125)
Net loss per share attributable to common stockholders, basic	$ (0.23)	$ (0.69)
Net loss per share attributable to common stockholders, diluted	$ (0.23)	$ (0.69)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic	39,042,445	38,321,573
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	39,042,445	38,321,573